Cancers influencing the female reproductive system, which includes ovarian, uterine, cervical, vulvar, and vaginal cancers, are referred to as gynaecologic malignancies that are The aim of this research is to benefit women who these malignancies have impacted through enhancement of earlier detection, treatment outcomes, and mortality. Due to non-specific symptoms, late-stage diagnoses are prevalent, and compared to other cancer types, research funding is usually scarce. Women are being enlightened about symptoms and risk factors through awareness campaigns, while research initiatives and income are being pushed for through campaigns for change